A Resilient Industry: M&A Trends in Specialty Pharmacy

A Resilient Industry: M&A Trends in Specialty Pharmacy

Significant changes have swept the specialty pharmacy market over the past several years. It was once a niche in the pharmacy industry but has grown significantly in market size. According to a report by Axtria, specialty drug spending is growing and constituted about 46% ($222.9 billion) of all prescription drugs in 2019, compared with 34.9% ($132 billion) in 2014. These numbers make sense with the tailwinds that pushed the industry, such as an aging population in the U.S. creating a greater need for medications that treat chronic and complex diseases.  Most of the changes in the market have come from M&A activity. Consolidation has swept the industry, with a few players controlling... Read More »
Elevance Health Acquires Specialty Pharmacy BioPlus

Elevance Health Acquires Specialty Pharmacy BioPlus

Elevance Health acquired Altamonte Springs, Florida-based specialty pharmacy BioPlus from CarepathRx. Terms of the deal were not disclosed. BioPlus provides services for patients living with complex and chronic conditions, such as cancer, multiple sclerosis, Hepatitis C, autoimmune diseases and rheumatology. Indianapolis-based Elevance Health connects consumers, families and communities to the care, support and resources they need. Its companies serve more than 119 million people through a portfolio of medical, digital, pharmacy, behavioral, clinical and complex care solutions. According to the LevinPro HC database, this was the 23rd specialty pharmacy transaction of 2022. This compares... Read More »
Elevance Health Acquires Specialty Pharmacy BioPlus

WindRose Health Investors acquires Specialty Pharmacy Bank’s Apothecary

WindRose Health Investors, LLC, a New York-based healthcare private equity firm, announced that it has completed the acquisition of Bank’s Apothecary. Bank’s Apothecary will merge with WindRose’s portfolio companies Terrapin Pharmacy and Ganse Apothecary, significantly expanding the footprint of WindRose’s behavioral health pharmacy platform. Terms of the transaction were not disclosed. Westcove Partners acted as financial advisor to Bank’s. Latham & Watkins LLP acted as legal advisor to WindRose, and Epstein, Becker & Green acted as legal advisor to Bank’s. Terms of the transaction were not disclosed. Bank’s Apothecary is an independent accredited... Read More »
BD Enters New Pharmacy Automation Solutions Market With Parata Systems Acquisition

BD Enters New Pharmacy Automation Solutions Market With Parata Systems Acquisition

On June 6, Becton, Dickinson and Company (BD), a leading global medical technology company, entered into a definitive agreement to acquire Parata Systems, an innovative provider of pharmacy automation solutions, for $1.53 billion from leading private equity firm Frazier Healthcare Partners. The transaction will be complementary to BD’s solutions in medication management with a new set of technologies across the care continuum, including acute care health systems, retail pharmacies, long-term care and home settings. Ropes & Gray LLP advised Becton, Dickinson and Company in the acquisition. Parata provides BD access to a new $600 million pharmacy automation market segment that is... Read More »
Walgreens Acquires Pharmacy Company Shields Health Solutions

Walgreens Acquires Pharmacy Company Shields Health Solutions

Walgreens Boots Alliance, Inc. (WBA), the holding company that owns the retail pharmacy chain Walgreens, has announced a new majority investment for Shields Health Solutions valued at $970 million. Shields Health Solutions is a specialty pharmacy that partners with hospitals and health systems to provide integrated care management for special disease states. Over the last two years, Shields has rapidly expanded its platform, representing more than one million specialty patients across more than 30 disease states, with more than 70 health system partners nationwide.WBA will acquire approximately 71% ownership of Shields, with an option to acquire the remaining equity interests in the... Read More »
Centric Buys Specialty Pharmacy Network

Centric Buys Specialty Pharmacy Network

Centric Health Corporation (TSE: CHH) is on its way to becoming the largest specialty pharmacy company serving seniors in Canada, thanks to its recently announced acquisition of Remedy Holdings Inc. The price is approximately US$27.2 million. This is the second deal in March 2020 targeting special services for seniors. Early in the month, NaviHealth acquired Innovative Healthcare Delivery IHD delivers a high-touch, patient-centric and non-clinical approach that is paired with proprietary workflow and patient engagement technology to help seniors to better understand and participate in their care plans.   In February, Guardian Pharmacy Services added to its Florida holdings with... Read More »